GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a truly shift in how we handle diabetes mellitus . These new therapies work by mimicking the body’s own GLP-1 process, which supports https://techonpage.com/story7176870/glp-1-a-major-approach-in-blood-sugar-treatment